From the Delaware Biotechnology Institute and.
the Howard Hughes Medical Institute, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390.
J Biol Chem. 2019 Apr 19;294(16):6405-6415. doi: 10.1074/jbc.RA118.007086. Epub 2019 Feb 7.
Upon phagocytosis into macrophages, the intracellular bacterial pathogen secretes effector proteins that manipulate host cell components, enabling it to evade lysosomal degradation. However, the bacterial proteins involved in this evasion are incompletely characterized. Here we show that the effector protein RavD targets host membrane compartments and contributes to the molecular mechanism the pathogen uses to prevent encounters with lysosomes. Protein-lipid binding assays revealed that RavD selectively binds phosphatidylinositol-3-phosphate (PI(3)P) We further determined that a C-terminal RavD region mediates the interaction with PI(3)P and that this interaction requires Arg-292. In transiently transfected mammalian cells, mCherry-RavD colocalized with the early endosome marker EGFP-Rab5 as well as the PI(3)P biosensor EGFP-2×FYVE. However, treatment with the phosphoinositide 3-kinase inhibitor wortmannin did not disrupt localization of mCherry-RavD to endosomal compartments, suggesting that RavD's interaction with PI(3)P is not necessary to anchor RavD to endosomal membranes. Using superresolution and immunogold transmission EM, we observed that, upon translocation into macrophages, RavD was retained onto the -containing vacuole and was also present on small vesicles adjacent to the vacuole. We also report that despite no detectable effects on intracellular growth of within macrophages or amebae, the lack of RavD significantly increased the number of vacuoles that accumulate the late endosome/lysosome marker LAMP-1 during macrophage infection. Together, our findings suggest that, although not required for intracellular replication of , RavD is a part of the molecular mechanism that steers the containing vacuole away from endolysosomal maturation pathways.
吞噬进入巨噬细胞后,细胞内细菌病原体分泌效应蛋白,操纵宿主细胞成分,使其逃避溶酶体降解。然而,参与这种逃避的细菌蛋白尚未完全表征。在这里,我们表明效应蛋白 RavD 靶向宿主膜区室,并有助于病原体用于防止与溶酶体相遇的分子机制。蛋白-脂质结合测定表明,RavD 选择性地结合磷脂酰肌醇-3-磷酸(PI(3)P)。我们进一步确定 RavD 的 C 末端区域介导与 PI(3)P 的相互作用,并且这种相互作用需要 Arg-292。在瞬时转染的哺乳动物细胞中,mCherry-RavD 与早期内体标记物 EGFP-Rab5 以及 PI(3)P 生物传感器 EGFP-2×FYVE 共定位。然而,用磷酸肌醇 3-激酶抑制剂wortmannin 处理不会破坏 mCherry-RavD 到内体区室的定位,这表明 RavD 与 PI(3)P 的相互作用对于将 RavD 锚定在内体膜上不是必需的。使用超分辨率和免疫金透射电子显微镜,我们观察到 RavD 在易位进入巨噬细胞后被保留在含有 -的空泡上,并且也存在于空泡旁边的小泡上。我们还报告说,尽管 RavD 对巨噬细胞或变形虫内的 细胞内生长没有可检测的影响,但 RavD 的缺乏显着增加了在巨噬细胞感染过程中积累晚期内体/溶酶体标记物 LAMP-1 的空泡数量。总之,我们的研究结果表明,尽管 RavD 不是 细胞内复制所必需的,但它是引导含有空泡远离内溶酶体成熟途径的分子机制的一部分。